Guardant Health, Inc.【GH】 業績推移・財務諸表

(単位:千ドル) 3Q18 1Q19 2Q19 3Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25 2Q25
売上高 21,692 36,655 53,975 60,848 67,510 66,335 74,569 78,665 92,101 94,779 96,099 109,144 117,404 128,714 137,150 143,030 168,491 177,235 191,476 203,471 232,088
売上成長率(%) - - -
売上原価 - - - - - - - - - - - - - - - - - - - 74,723 81,205
研究開発費 14,253 16,316 19,532 24,569 37,016 36,319 36,245 55,508 63,724 70,968 81,757 85,455 100,017 93,128 90,359 93,851 83,802 83,102 87,306 88,521 87,449
営業費用 45,897 60,319 69,243 78,325 102,422 120,955 148,821 186,528 189,743 202,067 219,437 239,465 262,004 262,769 256,766 256,573 268,174 277,853 308,804 314,512 338,501
営業利益 -24,205 -23,664 -15,268 -17,477 -34,912 -54,620 -74,252 -107,863 -97,642 -107,288 -123,338 -130,321 -144,600 -134,055 -119,616 -113,543 -99,683 -100,618 -117,328 -111,041 -106,413
営業利益率 (%)
経常(税引前)利益 -23,508 -21,325 -12,507 -13,292 -31,815 -49,705 -71,602 -107,248 -97,492 -107,430 -123,252 -228,986 -161,879 -133,293 -72,275 -85,612 -114,580 -102,495 -107,724 -94,869 -99,861
経常(税引前)利益率(%) -108.37 -58.18 -23.17 -21.84 -47.13 -74.93 -96.02 -136.34 -105.85 -113.35 -128.26 -209.8 -137.88 -103.56 -52.7 -59.86 -68.0 -57.83 -56.26 -46.63 -43.03
法人税等合計 0 26 -1,207 -202 14 34 68 110 83 96 -24 446 115 240 496 490 405 133 30 290 38
実効税率(%)
純利益 -23,508 -21,351 -11,300 -13,090 -31,829 -49,739 -71,670 -107,358 -97,575 -107,526 -123,228 -229,432 -161,994 -133,533 -72,771 -86,102 -114,985 -102,628 -107,754 -95,159 -99,899
純利益率(%)
一株あたり利益 - - - - - - - - -0.96 -1.06 -1.21 -2.25 -1.58 -1.3 -0.67 -0.73 -0.94 -0.84 -0.88 -0.77 -0.8
希薄化後一株あたり利益 - - - - - - - - -0.96 -1.06 -1.21 -2.25 -1.58 -1.3 -0.67 -0.73 -0.94 -0.84 -0.88 -0.77 -0.8
EBITDA - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - -